The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities
Open accessAbstract
The paraoxonase (PON) gene family in humans has three members, PON1, PON2, and PON3. Their physiological role(s) and natural substrates are uncertain. We developed a baculovirus-mediated expression system, suitable for all three human PONs, and optimized procedures for their purification. The recombinant PONs are glycosylated with high-mannose-type sugars, which are important for protein stability but are not essential for their enzymatic activities. Enzymatic characterization of the purified PONs has revealed them to be lactonases/lactonizing enzymes, with some overlapping substrates (e.g., aromatic lactones), but also to have distinctive substrate specificities. All three PONs metabolized very efficiently 5-hydroxy-eicosatetraenoic acid 1,5-lactone and 4-hydroxy-docosahexaenoic acid, which are products of both enzymatic and nonenzymatic oxidation of arachidonic acid and docosahexaenoic acid, respectively, and may represent the PONs' endogenous substrates. Organophosphates are hydrolyzed almost exclusively by PON1, whereas bulky drug substrates such as lovastatin and spironolactone are hydrolyzed only by PON3. Of special interest is the ability of the human PONs, especially PON2, to hydrolyze and thereby inactivate N-acyl-homoserine lactones, which are quorum-sensing signals of pathogenic bacteria. None of the recombinant PONs protected low density lipoprotein against copper-induced oxidation in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Current Protocols in Molecular Biology
(2001) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471142727 · Cited by 2,398
Aviram, M., Rosenblat, M., Bisgaier, C. L., Newton, R. S., Primo-Parmo, S. L., & La Du, B. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1649 · Cited by 1,168
Self-citationWatson, A. D., Berliner, J. A., Hama, S. Y., La Du, B. N., Faull, K. F., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118359 · Cited by 1,154
Self-citationMice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
Shih, D. M., Gu, L., Xia, Y.-R., Navab, M., Li, W.-F., Hama, S., Castellani, L. W., Furlong, C. E., Costa, L. G., Fogelman, A. M., et al. (1998) · Nature · doi:10.1038/28406 · Cited by 1,078
Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein
Mackness, M. I., Arrol, S., & Durrington, P. N. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80962-3 · Cited by 977
Starch-gel electrophoresis—Application to the classification of pituitary proteins and polypeptides
Ferguson, K. A. (1964) · Metabolism · doi:10.1016/s0026-0495(64)80018-4 · Cited by 965
Paraoxonase and Atherosclerosis
Durrington, P. N., Mackness, B., & Mackness, M. I. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.4.473 · Cited by 818
A second N-acylhomoserine lactone signal produced by Pseudomonas aeruginosa.
Pearson, J. P., Passador, L., Iglewski, B. H., & Greenberg, E. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1490 · Cited by 784
The human serum paraoxonase/arylesterase polymorphism.
Eckerson, H. W., Wyte, C. M., & Du, B. N. L. (1983) · PubMed · Cited by 732
The Human Serum Paraoxonase/Arylesterase Gene (PON1) Is One Member of a Multigene Family
Primo-Parmo, S. L., Sorenson, R. C., Teiber, J., & Du, B. N. L. (1996) · Genomics · doi:10.1006/geno.1996.0225 · Cited by 673
Self-citationHarel, M., Aharoni, A., Gaidukov, L., Brumshtein, B., Khersonsky, O., Meged, R., Dvir, H., Ravelli, R. B. G., McCarthy, A., Toker, L., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb767 · Cited by 646
The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin
Davies, H. G., Richter, R. J., Keifer, M., Broomfield, C. A., Sowalla, J., & Furlong, C. E. (1996) · Nature Genetics · doi:10.1038/ng1196-334 · Cited by 603
Aviram, M., Rosenblat, M., Billecke, S., Erogul, J., Sorenson, R., Bisgaier, C. L., Newton, R. S., & La Du, B. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00272-x · Cited by 596
Self-citationPharmacogenetics of paraoxonases: a brief review
Draganov, D. I., & Du, B. N. L. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0833-1 · Cited by 489
Self-citationNg, C. J., Wadleigh, D. J., Gangopadhyay, A., Hama, S., Grijalva, V. R., Navab, M., Fogelman, A. M., & Reddy, S. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105660200 · Cited by 466
Human Serum Paraoxonase (pon1) Isozymes Q and R Hydrolyze Lactones and Cyclic Carbonate Esters
Billecke, S., Draganov, D., Counsell, R., Stetson, P., Watson, C., Hsu, C., & Du, B. N. L. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15082-9 · Cited by 402
Self-citationReddy, S. T., Wadleigh, D. J., Grijalva, V., Ng, C., Hama, S., Gangopadhyay, A., Shih, D. M., Lusis, A. J., Navab, M., & Fogelman, A. M. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.4.542 · Cited by 370
Tateda, K., Ishii, Y., Horikawa, M., Matsumoto, T., Miyairi, S., Pechere, J. C., Standiford, T. J., Ishiguro, M., & Yamaguchi, K. (2003) · Infection and Immunity · doi:10.1128/iai.71.10.5785-5793.2003 · Cited by 346
Draganov, D. I., Stetson, P. L., Watson, C. E., Billecke, S. S., & La Du, B. N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004543200 · Cited by 338
Self-citationSorenson, R. C., Bisgaier, C. L., Aviram, M., Hsu, C., Billecke, S., & La Du, B. N. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.9.2214 · Cited by 324
Self-citationSerhan, C. N., Gotlinger, K., Hong, S., & Arita, M. (2004) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.03.005 · Cited by 310
Inactivation of a Pseudomonas aeruginosa quorum-sensing signal by human airway epithelia
Chun, C. K., Ozer, E. A., Welsh, M. J., Zabner, J., & Greenberg, E. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308750101 · Cited by 290
Costa, L. G., Cole, T. B., Jarvik, G. P., & Furlong, C. E. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152421 · Cited by 264
Oltman, C. L., Weintraub, N. L., VanRollins, M., & Dellsperger, K. C. (1998) · Circulation Research · doi:10.1161/01.res.83.9.932 · Cited by 249
Furlong, C. E., Richter, R. J., Seidel, S. L., Costa, L. G., & Motulsky, A. G. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90424-7 · Cited by 230
On the physiological role(s) of the paraoxonases
La Du, B. N., Aviram, M., Billecke, S., Navab, M., Primo-Parmo, S., Sorenson, R. C., & Standiford, T. J. (1999) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(99)00049-6 · Cited by 193
Self-citationMochizuki, H., Scherer, S. W., Xi, T., Nickle, D. C., Majer, M., Huizenga, J. J., Tsui, L.-C., & Prochazka, M. (1998) · Gene · doi:10.1016/s0378-1119(98)00193-0 · Cited by 180
Differential Immune Modulatory Activity of Pseudomonas aeruginosa Quorum-Sensing Signal Molecules
Hooi, D. S. W., Bycroft, B. W., Chhabra, S. R., Williams, P., & Pritchard, D. I. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6463-6470.2004 · Cited by 176
Marathe, G. K., Zimmerman, G. A., & McIntyre, T. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211126200 · Cited by 173
Molecular weights of protein multimers from polyacrylamide gel electrophoresis
Bryan, J. K. (1977) · Analytical Biochemistry · doi:10.1016/0003-2697(77)90111-7 · Cited by 167
Rosenblat, M., Draganov, D., Watson, C. E., Bisgaier, C. L., La Du, B. N., & Aviram, M. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000059385.95664.4d · Cited by 167
Self-citationLactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3
Teiber, J. F., Draganov, D. I., & Du, B. N. L. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00401-5 · Cited by 153
Self-citationHydrolysis of platelet-activating factor by human serum paraoxonase
Rodrigo, L. S., Mackness, B., Durrington, P. N., Hernández, A. F., & Mackness, M. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3540001 · Cited by 138
Calcium binding by human and rabbit serum paraoxonases. Structural stability and enzymatic activity.
Kuo, C. L., & Bn, L. D. (1998) · PubMed · Cited by 115
Roche, D. M., Byers, J. T., Smith, D. S., Glansdorp, F. G., Spring, D. R., & Welch, M. (2004) · Microbiology · doi:10.1099/mic.0.26977-0 · Cited by 100
Lipoxins: Potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease
Kieran, N. E., MADERNA, P., & Godson, C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00487.x · Cited by 97
Hydrolysis of platelet-activating factor by human serum paraoxonase
Rodrigo, L. S., Mackness, B., Durrington, P. N., Hernández, A. F., & Mackness, M. (2001) · Biochemical Journal · doi:10.1042/bj3540001 · Cited by 96
Multiple Substrates for Paraoxonase-1 during Oxidation of Phosphatidylcholine by Peroxynitrite
Ahmed, Z., Ravandi, A., Maguire, G. F., Emili, A., Draganov, D. I., Du, B. N. L., Kuksis, A., & Connelly, P. W. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6150 · Cited by 86
Self-citationEnzymes hydrolysing organophosphorus compounds
Loison, M. G. (1990) · Biochimie · doi:10.1016/0300-9084(90)90180-o · Cited by 86
Teiber, J. F., Draganov, D. I., & Du, B. N. L. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400213-jlr200 · Cited by 76
Self-citationCHANG, J. Y., Blazek, E. M., Kreft, A. F., et al. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90701-4 · Cited by 72
Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite
Connelly, P. W., Draganov, D. I., & Maguire, G. F. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.10.010 · Cited by 71
Self-citationIodolactones and iodoaldehydes — mediators of iodine in thyroid autoregulation
Dugrillon, A. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211700 · Cited by 68
INTRODUCTION OF DNA INTO MAMMALIAN CELLS
van der Eb, A. J. (1994) · Elsevier eBooks · doi:10.1016/b978-0-7506-1845-8.50008-9 · Cited by 64
Introduction of DNA into Mammalian Cells
Kingston, R. E. (2003) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb0900s64 · Cited by 55
Kerdesky, F. A. J., Schmidt, S. P., Holms, J. H., et al. (1987) · Journal of Medicinal Chemistry · doi:10.1021/jm00390a010 · Cited by 42
Identification of paraoxonase 3 in rat liver microsomes: purification and biochemical properties
Rodrigo, L. S., Gil, F., Hernández, A. F., LOPEZ, O., & Pla, A. (2003) · Biochemical Journal · doi:10.1042/bj20030732 · Cited by 41
CHD and Atherosclerosis: Human Epidemiological Studies and Transgenic Mouse Models
Shih, D. M., Reddy, S. T., & Lusis, A. J. (2002) · Springer eBooks · doi:10.1007/978-1-4615-1027-7_5 · Cited by 17
Cited by
Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis
Förstermann, U., Xia, N., & Li, H. (2017) · Circulation Research · doi:10.1161/circresaha.116.309326 · Cited by 1,519
Enzyme promiscuity: A mechanistic and evolutionary perspective
Tawfik, O. K. A. D. S. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-030409-143718 · Cited by 1,355
Targeting virulence: a new paradigm for antimicrobial therapy
Clatworthy, A. E., Pierson, E., & Hung, D. T. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.24 · Cited by 1,406
Bassler, B. L., & Losick, R. (2006) · Cell · doi:10.1016/j.cell.2006.04.001 · Cited by 983
Exploiting Quorum Sensing To Confuse Bacterial Pathogens
LaSarre, B., & Federle, M. J. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00046-12 · Cited by 820
Metadata
- Authors
- Draganov, D. I., Teiber, J. F., Speelman, A., Osawa, Y., Sunahara, R., & La Du, B. N.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 46
- Issue
- 6
- Pages
- 1239-1247
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2164259487
- Cited by
- 715
- References
- 49
- FWCI
- 22.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.